Prescription Audit as a Quality Improvement Tool: Impact of Repeated Interventions in Paediatric Outpatient

Prajwal B Gadgeesh1, Vikram Sakaleshpur Kumar2,3, Niveditha Hegde Venkatramana4

  • 1Pediatrics and Neonatology, Subbaiah Institute of Medical Sciences, Shivamogga, IND.

Cureus
|January 12, 2026
PubMed

Insights

Repeated prescription audits in a low-resource hospital significantly improved prescribing quality and documentation. Continuous reinforcement is needed for sustained improvements in rational drug use.

Area of Science:

  • Healthcare Quality Improvement
  • Clinical Pharmacy
  • Global Health

Background:

  • Prescription auditing is infrequent in low- and middle-income countries (LMICs) due to infrastructure and quality-assurance limitations.
  • This study addresses the need for effective prescribing practices in LMIC pediatric settings.

Purpose of the Study:

  • To evaluate the impact of repeated audit-feedback cycles on prescription completeness and rational drug use.
  • To assess the sustainability of improvements in prescribing quality over time in a tertiary pediatric hospital.

Main Methods:

  • A prospective, repeated cross-sectional audit of 10 cycles was conducted over 12 months.
  • A manual, paper-based audit-feedback process with prescriber education was implemented.
  • The Plan-Do-Study-Act (PDSA) model guided the intervention, with a re-audit after eight months.

Main Results:

  • Significant improvements were observed in documentation completeness (OPD numbers 50% to 99%) and legibility (30% to 90%).
  • Generic prescribing increased from 60% to 92%, while the mean number of drugs per prescription decreased from 4.4 to 1.5.
  • Antibiotic use reduced from 80% to 20%, though allergy documentation remained modest (0% to 32%).
  • A slight regression was noted in the re-audit, highlighting the need for ongoing reinforcement.

Conclusions:

  • Cost-neutral audit-feedback cycles can substantially enhance prescribing quality and drug stewardship in LMIC settings, even without digital systems.
  • Sustained improvements necessitate integrating audit processes into hospital governance structures.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
250